Market Cap (In USD)
62.9 Million
Revenue (In USD)
608.52 Thousand
Net Income (In USD)
-3.17 Million
Avg. Volume
18.01 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.252-1.76
- PE
- -
- EPS
- -
- Beta Value
- -740.143
- ISIN
- US67059V2097
- CUSIP
- 67059V209
- CIK
- 1091596
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. David E. Jorden CPA
- Employee Count
- -
- Website
- https://www.nuot.com
- Ipo Date
- 2017-10-24
- Details
- Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.
More Stocks
-
TREAY
-
EQUITASBNKEquitas Small Finance Bank Limited
EQUITASBNK
-
GLATF
-
WORWorley Limited
WOR
-
SCSCScanSource, Inc.
SCSC
-
IOB
-
LDSNLuduson G Inc.
LDSN
-
SHPHF